UK Blood Collection Devices Market Overview, 2031

Key Insights

• According to the research report, "UK Blood Collection Devices Market Outlook, 2031," published by Bonafide Research, the UK Blood Collection Devices Market is anticipated to grow at more than 8.10% CAGR from 2026 to 2031.
• The UK market operates under the centralized framework of the National Health Service (NHS), primarily coordinated through NHS Supply Chain. This framework favors bulk-procured, standardized closed vacuum tubes, safety-engineered winged collection sets, and blood transfer units. Procurement contracts heavily emphasize lower overall unit costs and long-term volume consistency, limiting market entry for standalone unintegrated consumables while driving high adoption for standardized supply portfolios across NHS trusts.
• To alleviate pressure on overcrowded hospital outpatient phlebotomy clinics, the UK healthcare system is rapidly shifting routine monitoring toward primary care, community diagnostic hubs, and home settings. NHS initiatives increasingly incorporate upper-arm capillary microsampling devices and volumetric absorptive micro-sampling (VAM) tools. These push-button systems enable decentralized monitoring for chronic condition management, therapeutic drug monitoring, and large-scale academic clinical trials without requiring an in-person venous draw.
• A major breakthrough transforming UK diagnostic testing is the deployment and clinical trial integration of advanced micro-fluidic fingerstick sampling and AI-assisted blood draw systems. These technologies, evaluated in partnership with major NHS trust research hubs, combine near-infrared vein illumination with micro-fluidic separation to allow immediate, pain-reduced point-of-care capillary collection. This drastically reduces sample pre-analytical hemolysis and speeds up point-of-care lab processing times.

Market Outlook

• The ongoing expansion of NHS Community Diagnostic Centres across England will shift blood collection volumes out of major acute hospitals into local retail and community sites. This shift will accelerate demand for portable blood collection kits, automated tube pre-labeling devices, and specialized ambient transport containers designed for multi-site collection routes.
• Under the NHS Net Zero Supplier Roadmap, blood collection manufacturers supplying the UK market must meet strict carbon footprint, packaging reduction, and circular economy targets. Device vendors are increasingly required to transition toward bio-based polymers, lightweight single-use plastics, and reduced secondary packaging to maintain eligibility in regional NHS Supply Chain tender awards.
• Major market suppliers include Becton, Dickinson and Company (BD UK), Greiner Bio-One Ltd, Sarstedt Ltd, Terumo Blood and Cell Technologies, and Fresenius Kabi UK, operating alongside key governing organizations such as NHS Blood and Transplant (NHSBT), the MHRA (Medicines and Healthcare products Regulatory Agency), the Health and Safety Executive (HSE), and the Institute of Biomedical Science (IBMS).

Market Dynamics

Driver: Shifting patient care to community diagnostic centres (CDCs) and primary care
To reduce acute hospital overcrowding and post-pandemic backlog across the NHS, the UK government is shifting routine clinical services away from major hospitals toward decentralized Community Diagnostic Centres (CDCs) and GP primary care hubs. This transition requires significant volumes of routine diagnostic testing closer to home, directly driving sustained NHS demand for portable, single-use blood collection hardware such as standardized vacuum collection tubes, safety butterfly sets, and closed transfer devices optimized for multi-site logistics and transport.
Challenge: NHS supply chain price squeezes and supply vulnerabilities
The UK market is heavily dominated by centralized procurement through NHS Supply Chain, which operates under strict cost-efficiency mandates and fixed framework agreements. Manufacturers face intense margin pressures on high-volume, single-use consumables like collection tubes and needles. Additionally, tight procurement budgets coupled with post-Brexit import friction and global supply chain disruptions have led to periodic regional shortages of critical phlebotomy supplies, making long-term supply resilience a persistent operational hurdle.
Trend: Rapid adoption of capillary microsampling and at-home collection
There is a growing shift across NHS research hubs, private diagnostic providers, and decentralized clinical trials toward capillary microsampling and volumetric absorptive micro-sampling (VAM) devices. These push-button micro-collection systems allow small amounts of blood to be sampled from the upper arm or finger with minimal pain. This trend aligns with the expansion of NHS virtual wards and remote monitoring, enabling patients to collect samples at home for mail-in laboratory analysis without requiring a trained phlebotomist.

Regulations and Policies

• MHRA Medical Device Registration and Regulation: All blood collection devices (e.g., evacuated tubes, lancets, needles, and blood donor bags) sold in Great Britain must be registered with the Medicines and Healthcare products Regulatory Agency (MHRA) under the UK Medical Devices Regulations 2002 (UK MDR 2002, as amended).
• UKCA Marking and CE Mark Recognition: Manufacturers supplying Great Britain must transition toward the UKCA (UK Conformity Assessed) mark. Under current MHRA transitional provisions, valid CE-marked devices under the EU MDD/IVDD or EU MDR/IVDR continue to be accepted on the GB market until transitional deadlines (ranging through 2028–2030 depending on device classification).
• UK Responsible Person (UKRP) Requirement: Foreign manufacturers located outside the United Kingdom must appoint a UK Responsible Person (UKRP) based in the UK to act on their behalf, handle device registration with the MHRA, and oversee post-market surveillance duties.
• Health and Safety (Sharp Instruments in Healthcare) Regulations 2013: Enforced by the Health and Safety Executive (HSE), this regulation legally mandates the implementation of safety-engineered medical devices (such as self-retracting lancets and shielded butterfly needles) across all healthcare environments to prevent occupational needlestick injuries among healthcare personnel.

Segment Analysis

UK Blood Collection Devices Market By Product Type
• Blood collection tubes in the UK are closely integrated with standardized pathology workflows, where the tube type, additive, order of draw, specimen volume, and handling procedure are linked to the intended laboratory test. NHS pathology services commonly provide specific tube guides and test-to-tube instructions, making compatibility with established local laboratory protocols an important purchasing consideration. The category is also influenced by the NHS's experience with blood-tube supply disruptions, which has increased attention to supply resilience, product standardization, and coordinated stock management.
• Needles and syringes are increasingly differentiated by healthcare-worker safety, ergonomic handling, blood-flow characteristics, and compatibility with closed specimen-collection systems. Within the UK, NHS procurement places considerable emphasis on clinical suitability when evaluating alternative products, meaning that switching collection needles can involve assessment of practical usability rather than being treated as a simple commodity substitution.
• Blood bags occupy a highly specialized position because they connect donation with the processing, storage, testing, distribution, and transfusion of blood components. In the UK, blood establishments and hospital blood banks operate under the Blood Safety and Quality Regulations, with the MHRA overseeing blood quality and safety. Consequently, blood-bag systems are valued for sterile closed collection, component integrity, traceability, compatibility with processing equipment, and reliable integration into transfusion workflows.
• Blood collection systems and monitors are particularly important in UK blood establishments and specialized apheresis environments, where collection is treated as a controlled process rather than simply a manual blood draw. Advanced systems can monitor blood flow, anticoagulant delivery, collection parameters, procedure completion, and safety conditions while incorporating alarms and safeguards. UK blood-service guidance has historically emphasized features such as blood-flow monitoring, air detection, anticoagulant-flow indicators, preset collection parameters, alarms, and manual override capabilities.
• Lancets are closely associated with capillary sampling, point-of-care diagnostics, diabetes-related testing, community healthcare, and situations where venous collection is unnecessary. In the UK, safety finger and heel lancets are explicitly included within NHS Supply Chain procurement categories, demonstrating that lancets are treated as a distinct clinical-supply segment rather than merely a low-value accessory. Product differentiation centers on controlled penetration, patient comfort, single-use construction, ease of activation, and sharps protection.
• Others category includes micro-collection devices, specimen-transfer accessories, capillary sampling components, adapters, specialized blood-draw accessories, and other products supporting blood acquisition and specimen management. In the UK, these products are increasingly connected to decentralized diagnostics and the need to reduce unnecessary handling between the patient and laboratory. Their importance is also evident in NHS procurement structures that combine blood-collection systems, lancets, blood-culture collection products, and related accessories into coordinated procurement frameworks.

UK Blood Collection Devices Market By End-User
• Hospitals and ambulatory surgical centres require blood collection devices across emergency medicine, inpatient care, surgery, critical care, outpatient procedures, and routine diagnostic testing. The UK hospital segment is distinctive because NHS procurement and clinical standardization encourage products that can be used consistently across departments while fitting established pathology and infection-control procedures. Hospitals also increasingly consider supply continuity and product interchangeability when selecting consumables, particularly following previous disruptions in blood-tube availability.
• Diagnostics and pathology laboratories place exceptional emphasis on pre-analytical specimen quality because collection errors can compromise the analytical process before the sample reaches the analyzer. UK pathology services commonly specify the correct tube, additive, collection sequence, and specimen requirements for individual tests, creating strong demand for standardized collection products.
• Blood banks and blood establishments have the most specialized collection requirements because blood collection directly feeds transfusion and blood-component processing. The UK regulatory framework places responsibility on the MHRA for regulating blood quality and safety, including blood establishments and hospital blood banks, while haemovigilance extends across donation, processing, distribution, and transfusion. This creates strong demand for collection systems with traceability, sterility, controlled processing, validated operating procedures, and compatibility with component-preparation workflows.
• Other users include general practices, community diagnostic centres, outpatient clinics, research facilities, occupational-health services, home-care settings, and point-of-care testing environments. Their requirements typically prioritize convenience, portability, simplified sampling, low-volume collection, and minimal specimen-handling steps. The NHS procurement structure for blood lancets and blood-draw accessories illustrates the importance of products suitable for settings beyond large hospitals.

UK Blood Collection Devices Market By Application
• Diagnostic blood collection is dominated by the need to preserve specimen integrity from patient identification and venepuncture through transport and laboratory analysis. UK pathology practice places considerable emphasis on selecting the appropriate collection tube and following the correct order of draw, with local pathology handbooks often specifying the exact tube and additive required for individual investigations. This creates a market environment where tube chemistry, specimen volume, labeling, collection sequence, transport stability, and compatibility with automated laboratory systems are key differentiators.
• Therapeutic blood collection is differentiated by the fact that the collected blood or blood component becomes part of a treatment or transfusion pathway rather than being used solely for diagnostic testing. It includes donor blood collection, component preparation, apheresis, therapeutic plasma-related procedures, and other blood-processing activities. UK requirements place strong emphasis on the safety and quality of blood components throughout collection, processing, storage, distribution, and transfusion.

UK Blood Collection Devices Market By Method
• Manual blood collection remains fundamental across the UK because venepuncture requires clinical judgment, patient assessment, appropriate vein selection, and adaptation to individual circumstances. Its continued importance is reinforced by the wide range of clinical settings in which blood is collected, from acute hospitals to primary care and community services. The market is therefore increasingly focused on making manual collection safer and more consistent through safety-engineered needles, standardized tube systems, ergonomic holders, single-use accessories, and simplified specimen-handling procedures.
• Automated blood collection is particularly relevant to UK blood establishments and apheresis services, where collection can involve simultaneous component separation, controlled anticoagulant administration, monitoring, and return of selected blood constituents. Automation reduces dependence on continuous manual intervention and can provide alarms, flow monitoring, preset collection parameters, safety interlocks, and procedure-completion controls. UK blood-service guidance has specifically emphasized these features as part of appropriately controlled blood-collection and apheresis equipment.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Blood Collection Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Blood Collection Tubes
• Needles & Syringes
• Blood Bags
• Blood Collection Systems/Monitors
• Lancets
• Others

By End-User
• Hospitals and ASCs
• Diagnostics and Pathology Laboratories
• Blood Banks
• Others

By Application
• Diagnostic Application
• Therapeutic Application

By Method
• Manual
• Automated